How much should we pay for medicines?
So when Gilead Sciences, the manufacturer of sofosbuvir, which goes by the brand name Sovaldi, announced its new drug was ready for prime time, doctors who treat patients with the disease cheered. Results of clinical trials showed side effects appeared … Read more on Ag Journal

Learning from the Kelly Thomas case
The broader problem is the lack of a comprehensive, treatment-based response to mental illness and the default decision to treat the symptoms and side effects — drug abuse, erratic behavior or homelessness — as entry points into the criminal justice … Read more on Los Angeles Times

La Jolla Pharmaceutical Company (LJPC): La Jolla Pharmaceutical – Can This …
After recently working at Reata Pharmaceutical working on the development of bardoxolone methyl for the treatment of Chronic Kidney Disease (CKD), she has come to La Jolla to continue CKD research. Reata's phase 3 BEACON trial for bardoxolone methyl in … Read more on Seeking Alpha

Hot New Biotech Knows Roller-Coaster Feeling
By last Friday, the 45-person firm was the hottest company in the biotechnology sector, its market capitalization having soared more than sixfold over the course of one week, to $ 8.6 billion from $ 1.4 billion, after its liver-disease drug performed … Read more on Wall Street Journal